Bankruptcy of Genetic Testing Giant Triggers State Response and Raises Questions about Privacy

Introduction

The recent Chapter 11 bankruptcy filing by genetic testing firm 23andMe has caused waves in the healthcare and consumer markets. The move has prompted several state authorities, including Ohio, to react with guidance and warning measures for consumers. The incident highlights larger issues regarding data privacy and the stability of the direct-to-consumer genetic testing market.​

23andMe’s Bankruptcy Filing

On March 24, 2025, 23andMe sought Chapter 11 bankruptcy protection. The firm listed over $214.7 million in debts against $277.4 million in assets. Co-founder and CEO Anne Wojcicki stepped down but will continue to serve on the board and plans to make a bid for the company’s assets during bankruptcy. In spite of these economic difficulties, 23andMe has arranged for $35 million in financing to help fund day-to-day operations throughout the reorganization process.

Ohio’s Response and Consumer Guidance

With consideration of the financial woes of 23andMe, Ohio’s Attorney General released a consumer alert instructing residents to mind the safety of their genetic information. Though precise information from Ohio officials is still awaited, other states’ actions give an indication of what recommendations might be made. California Attorney General Rob Bonta, for one, has asked consumers to think about deleting data and having whatever genetic information 23andMe stores destroyed.

Data Privacy Issues

The bankruptcy has heightened issues about the privacy and security of genetic information gathered by 23andMe. With more than 15 million customers’ genetic information possibly at stake in asset sales, concerns are raised about how this sensitive information will be treated by prospective buyers. Experts point out that, in bankruptcy situations, user information can be sold to new companies, possibly changing the initial privacy terms. ​

Industry Implications

23andMe’s financial woes are symptomatic of industry-wide difficulties in the direct-to-consumer genetic testing space. The company struggled with falling demand, increased privacy concerns due to a 2023 data breach involving close to 7 million customers, and a failure to create recurring streams of revenue. These conditions led to a precipitous decline in valuation from $3.5 billion to less than $50 million. ​

Protecting Your Genetic Data

With the existing uncertainties, customers are urged to take initiative measures to protect their genetic data:

Check Privacy Policies: Learn the terms of service and privacy policies of the companies offering genetic tests.​

Delete Personal Data: Consider asking the deletion of your genetic data and destruction of physical samples. 23andMe offers data deletion options via their customer care portal.

Stay Informed: Keep an eye on messages from 23andMe and state officials for news about the bankruptcy process and any steps that will impact your information.​

23andMe’s bankruptcy is a stern reminder of the need for data privacy and the dangers of releasing sensitive genetic data. Ohio’s reaction underscores the necessity for consumers to be cautious and proactive in guarding their personal information in the face of the changing genetic testing market.